Simulations Plus, Inc. (SLP) Earnings Preview: Reports After the Close
As seen on the 24/7 Wall St. homepage on July 9, 2026.
Simulations Plus reports after the bell as FDA's Operation TrialBlazer puts biosimulation tools in regulatory spotlights—watch whether the software segment captures that momentum.
Mentioned: SLP